Stay updated on Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial

Sign up to get notified when there's something new on the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.
    Difference
    0.1%
    Check dated 2025-04-30T18:02:35.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page has undergone significant changes, including the removal of detailed study information regarding the safety and efficacy of Nivolumab combined with Daratumumab for various advanced cancers, while retaining the mention of Janssen Biotech, Inc. as a collaborator and updating the revision number.
    Difference
    7%
    Check dated 2025-04-16T12:44:57.000Z thumbnail image
  5. Check
    30 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T05:39:46.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.2 to version 2.14.3.
    Difference
    0.1%
    Check dated 2025-04-01T22:41:09.000Z thumbnail image
  7. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-24T20:17:28.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    1%
    Check dated 2025-02-10T09:31:55.000Z thumbnail image

Stay in the know with updates to Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab-Daratumumab Combo in Advanced Cancers Clinical Trial page.